Skip to content

To Assess The Validity And Reliability Of Glittre-Activities Of Daily Living Test In Head And Neck Cancer Patients: A Cross-Sectional Study

Validity And Reliability Of Glittre – Activities Of Daily Living Test In Patients With Head And Neck Cancer Subjected To Chemoradiation Therapy: A Cross-Sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071059
Enrollment
58
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: nil: nil

Sponsors

Sharal Reshma Dsouza
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Population patients who are diagnosed with head and neck cancer stage IIIA to IVB Pre-treatment before starting with chemoradiotherapy AGE more than or equal to 18 years All genders Eastern Cooperative Oncology Group ECOG performance status scale Grade less than 2

Exclusion criteria

Exclusion criteria: Patients who are not hemodynamically stable like uncontrolled hypertension more than or equal to 140 mmHg systolic and 90 mmHg diastolic and a resting heart rate of more than or equal to 120 beats per minute Platelet count less than 50000 per µL Any known cardiac or respiratory disease or neurologic or orthopedic conditions that could interfere with the successful completion of the exercise tests and limit participation in the test Patients with psychological illness that can interfere with the test

Design outcomes

Primary

MeasureTime frame
To assess the validity of glitter-ADL test in patients with head and neck cancer subjected to chemoradiation therapyTimepoint: baseline

Secondary

MeasureTime frame
To find the reliability of the glitter-ADL test in patients with head & neck cancer subjected to chemoradiation therapyTimepoint: Baseline

Countries

India

Contacts

Public ContactProf Cherishma Dsilva

Father Muller College of Physiotherapy

cheri8585@gmail.com9663558311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026